Pharmaceutical companies have stepped up pressure on the Government to push back against proposed new regulations of the ...

Belgium's pharmaceutical sector is facing mounting domestic pressure from analysts concerned about the undermining of ...

President Trump signed the Lowering Drug Prices by Once Again Putting Americans First Executive Order (Executive Order). The ...

Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The ...

The top 20 biopharmas demonstrated a strong start to 2025, despite ongoing uncertainty surrounding Trump’s tariffs.

With potential tariffs and other drug pricing policies on the horizon, the industry is navigating uncertain waters. | The ...

Pharmacy benefit managers (PBMs) are up to bat in the perpetual blame game between PBMs and the pharmaceutical industry. | ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

Big Pharma, long a lobbying powerhouse in Washington, is struggling to settle on a strategy for defending itself against ...

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...

Pharmaceutical companies in Europe are requesting the EU to adopt drug pricing strategies comparable to the US.

On Thursday, 2084 stocks advanced, 1871 declined and 151 remained unchanged on Bombay Stock Exchange with advance decline ...